PRINCIPIA BIOPHARMA

Serial Number 98327861
Registration 7559121
700

Registration Progress

Application Filed
Dec 22, 2023
Under Examination
Approved for Publication
Aug 20, 2024
Published for Opposition
Aug 20, 2024
Registered
Nov 5, 2024

Trademark Image

PRINCIPIA BIOPHARMA

Basic Information

Serial Number
98327861
Registration Number
7559121
Filing Date
December 22, 2023
Registration Date
November 5, 2024
Published for Opposition
August 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 5, 2024
Registration
Registered
Classes
042

Rights Holder

Principia Biopharma Inc.

03
Address
55 Corporate Drive
Bridgewater, NJ 08807

Ownership History

Principia Biopharma Inc.

Original Applicant
03
Bridgewater, NJ

Principia Biopharma Inc.

Owner at Publication
03
Bridgewater, NJ

Principia Biopharma Inc.

Original Registrant
03
Bridgewater, NJ

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1831 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-05)
Due Date
November 05, 2030
Grace Period Ends
May 05, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Nov 5, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 5, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 20, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 17, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 16, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Dec 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of pharmaceutical preparations and medicines; pharmaceutical research and development.
First Use Anywhere: Jan 9, 2012
First Use in Commerce: Jan 9, 2012

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"